Search Results
Site Search
Learn more about how immunology testing at Mayo Clinic Laboratories can reveal genetic associations to disorders that impact the immune system.
September 2023 - Cardiovascular Pathology - Insights
This "Pathways" program provides an Anatomic Pathology case that includes a history, potential answers, rationale, and relevant references. This case sub-specialty is Cardiovascular Pathology.
CNS Demyelinating Disease Testing - Mayo Clinic Laboratories
We offer the only FACS assay for CNS Demyelinating Disease. Our testing ensures the highest senstivity and specificity, providing the most accurate results for patients.
New tests launched in February - Insights
In February 2023, Mayo Clinic Laboratories announced fifteen new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
Invasive fungal infection - Insights
Mayo Clinic Laboratories’ fungal biomarker test rapidly screens for invasive fungal infections caused by various fungal pathogens.
Six ways innovative lupus tests are transforming patient and clinician experiences - Insights
The Lupus Foundation of America estimates that at least five million people worldwide have a form of lupus. Yet, the most widely used laboratory tests for patients with this complex condition were developed more than 60 years ago, and...
Benign Hematology Testing - Mayo Clinic Laboratories
Our metabolic hematology laboratory is dedicated to providing accurate diagnoses and interpretations with an emphasis on clinical significance for your patients.
Neurodevelopmental disorders - Insights
Learn more about how chromosomal microarray can be used as a first-tier diagnostic test for those with congenital abnormalities and developmental disabilities.
Hereditary neuromuscular disorders - Insights
Find out how our distinctive approach to evaluating for inherited neuromuscular disorders uses phenotypic information to streamline diagnosis.
Present Approaches to Testing - Insights
Discussing current test applications that you can implement in your laboratory or practice today.
Mosquito-borne disease - Insights
View our comprehensive menu of individually orderable tests and panels for mosquito-borne diseases and our algorithmic approach to testing.
CMS Date of Service Policy - Insights
If your organization refers outpatient testing to Mayo Clinic Laboratories (MCL) for molecular pathology tests, the performing laboratory will be required to bill Medicare directly for tests that meet specific requirements. This new...
Testing Archives - Page 6 of 26 - Insights
Skip to Content MayoACCESS MayoLINK Register My Dashboard...
Mayo Clinic Laboratory and Pathology Research Roundup: July 23 - Insights
This week’s Research Roundup highlights gastrointestinal and extra-intestinal manifestations of immunoglobulin G4-related disease.
Mayo Clinic Laboratory and Pathology Research Roundup: Nov. 5 - Insights
This week’s Research Roundup highlights gastrointestinal and extra-intestinal manifestations of IgG4-related disease.
Week in Review: March 11 - Insights
Today's Highlights Include: MN has 14 hospitals in Newsweek's U.S. Top 500; Mayo best in the world, medical supplies head to Ukraine from Rochester, and how does your body react to stress?
Week in Review: March 25 - Insights
Today's Highlights Include: e-changing kidney swap, climate change is making allergy season even worse, and a Minnesota Milestone: A day without COVID-19 deaths.
New tests launched in May - Insights
In May 2022, Mayo Clinic Laboratories announced multiple new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
Browse our full menu of testing for motor and sensory neuropathies, spastic paraplegia, amyloidosis, and brachial plexus, among other conditions.
July 2023 - Cytopathology and Pulmonary Pathology - Insights
This "Pathways" program provides an Anatomic Pathology case that includes a history, potential answers, rationale, and relevant references. This case sub-specialty is Cytopathology & Pulmonary Pathology.
Short recordings surrounding disease diagnosis through new methods in testing and treatment.
5 Tips for Effectively Surveying Lab Customers - Insights
Surveys are crucial for strengthening laboratory operations. Get insights for how to make them as effective as possible.
Independence Day Specimen Shipping Guidelines and Schedule - Insights
Mayo Clinic Laboratories' specimen pickup and delivery schedules will be altered due to the upcoming July 4th holiday. To ensure specimen stability and prevent delays, follow the guidelines outlined below for domestic clients and...
PCD test provides definitive diagnosis of a rare disease - Insights
Joseph Maleszewski, M.D., and Marie-Christine Aubry, M.D., explain how Mayo Clinic Laboratory can provide definitive diagnosis of primary ciliary dyskinesia (PCD). Mayo Clinic's expertise and technology have earned the laboratory's...
Addiction rehab monitoring assay - Insights
Paul Jannetto, Ph.D., and Loralie Langman, Ph.D., discuss Mayo Clinic Laboratories' unique approach to urine drug testing for addiction rehabilitation. Designed to guide and monitor therapy, the comprehensive profile tests for the most...
Genetic Testing to Enhance Multiple Myeloma Treatment - Insights
Multiple myeloma is the second most common blood cancer, but most people haven’t heard of it until they or someone they know is diagnosed with the disease. March is Myeloma Action Month—a time to focus attention on the fight against...
Zhiyv (Neal) Niu, Ph.D., and Christopher Klein, M.D., explain how Mayo Clinic Laboratories' updated neuromuscular gene panel informs diagnosis and treatment. The phenotype-based panel covers the complete list of neuromuscular genes and...
Angela Pickart, M.S., CGC, and Emily Lauer, M.S., CGC, explain how Mayo Clinic Laboratories' multigene panel helps identify the cause of hereditary ataxia. Precise diagnosis of this complex movement disorder helps guide patient treatment...
Zhiyv (Neal) Niu, Ph.D., and Rodolfo Savica, M.D., Ph.D., explain why Mayo Clinic Laboratories' gene panel is the most comprehensive test available for inherited Parkinson's disease. The new panel covers all mutations known to cause the...
Five Steps to Optimizing Your Outreach Test Menu - Insights
With changes in technology, medical practice, and market trends, and the expansion of health system services, the laboratory test menu can be ever in flux. It is essential that the laboratory test menu keeps up with trends, remaining...
Chromosomal microarray better informs brain tumor diagnosis - Insights
Molecular biomarkers are a critical component in the treatment of adult and pediatric brain tumors. Robert Jenkins, M.D., Ph.D., explains how Mayo Clinic Laboratories' chromosomal microarray provides more comprehensive and accurate tumor...
Results report simplifies urine test interpretation: John Lieske, M.D. - Insights
John Lieske, M.D., explains why it's now easier for clinicians to pull information from Mayo Clinic Laboratories' supersaturation test report. An updated format summarizes complex information to help guide the treatment of kidney stones.
NELL-1 [Test in Focus] - Insights
Sanjeev Sethi, M.D., Ph.D., discusses how Mayo Clinic Laboratories’ new immunohistochemistry test for the detection of NELL-1 antigen, a biomarker for membranous nephropathy found in 10% to 15% of patients, provides diagnostic certainty and...
Inflammatory Bowel Disease: IBDP2 - Insights
In this test specific episode of the "Answers From the Lab" podcast, Melissa Snyder, Ph.D., explains how IBDP2, when used after first-line testing has failed, can distinguish between ulcerative colitis and Crohn’s disease.
Is the term "outreach" obsolete? - Insights
In a competitive outpatient testing market, choosing a laboratory is discretionary. With the goal of becoming the laboratory of choice for discretionary outpatient testing, it no longer matters if it is called “inreach” or “outreach.” While...
Pancreatic Elastase - Insights
Puanani Hopson, D.O., a Mayo Clinic pediatric gastroenterologist, explains the pancreatic elastase test — a screening test that can be useful when symptoms point to the possibility of exocrine pancreatic insufficiency. Dr. Hopson reviews...
Direct Ethanol Biomarker Testing: PETH - Insights
Paul Jannetto, Ph.D., describes Mayo Clinic Laboratories' new direct biomarker test for alcohol consumption. PETH is a blood test with a window of detection of about two to four weeks — compared with five days for urine-based screening for...
RNA test identifies large B-cell lymphoma subtypes: Lisa Rimsza, M.D. - Insights
Lisa Rimsza, M.D., explains how Mayo Clinic Laboratories' unique PM3CX test can accurately determine subtypes of large B-cell lymphoma. Precise diagnosis is critical to choosing appropriate chemotherapy.
Examining dendritic cells to uncover immunity defects - Insights
Dendritic cells play a crucial role in the body's immune response. Research has shown that too few of these cells in the blood may signal a defect in innate immunity. Up to this point, however, no clinical test has been available to count...
Aiming to advance understanding of hard-to-predict gastroenteropancreatic neuroendocrine tumors (GEP-NETs), Thermo Fisher Scientific joined forces with Mayo Clinic and BioPharma Diagnostics to validate and gain U.S. regulatory clearance of...
Shining light on one family's struggle: Barbara, Deborah, Pamela, and Rylie - Insights
Before testing at Mayo Clinic Laboratories, Barbara Domaille, Deborah Neville, Pamela Neville, and Rylie Ronnenberg thought there could be a genetic connection to the hip problems they shared. After the testing, they knew for sure.
Using metal detectors to ward off wayward specimens - Insights
To safeguard patient samples, staff in Mayo Clinic’s Histology Laboratory devised an inventive way to ensure that none of the paraffin-embedded blocks processed in the lab ever ends up in the trash.
The Power of Discovery: Mayo Clinic Laboratories Autoimmune Neurology Service - Insights
Autoimmune neurological disorders can often be treated, sometimes with full restoration of function. However, because the symptoms mimic other conditions, autoimmune neurological disorders are frequently misdiagnosed, resulting in an...
Outreach & Business Solutions - Insights
Mayo Clinic Laboratories’ Outreach Program equips laboratory leaders with Mayo Clinic expertise and customized strategies to help grow laboratory revenues by increasing efficiencies and minimizing waste.
Saving and improving lives: The illuminating journey of a laboratory testing specimen - Insights
Check out the first episode of “Life of a Specimen,” a video series that examines the critical journey taken by patient samples through Mayo Clinic Laboratories testing. In this video, we learn about the profound impact of our testing on...
GFAP: Novel Test for a Newly Identified Meningoencephalomyelitis - Insights
Mayo Clinic Laboratories is the only laboratory in the world to offer testing for a novel form of autoimmune meningoencephalomyelitis. Known as autoimmune glial fibrillary acidic protein (GFAP) astrocytopathy, the condition was identified...
Living in the moment: Susan Parrott - Insights
As someone affected by chronic liver disease, Susan Parrott knows how it feels to live in uncertainty. But every few months, the anxiety and doubt that shadow her life fade when Mayo Clinic Laboratories test results confirm her condition is...
Behind the scenes in neural antibody testing - Insights
In this month’s “Hot Topic,” John Mills, Ph.D., explains the central role of tissue immunofluorescence in the identification of neural antibodies and discusses the benefits of an integrated laboratory approach to the development and...
Heartbeats of gratitude: Scott Olson - Insights
In a quiet suburb outside of Minneapolis, Minnesota, an ordinary Saturday took a sudden and alarming turn for Scott Olson when he began experiencing symptoms of ventricular tachycardia. Central to the care and treatment he'd receive at Mayo...
Myeloid Blast and Maturation Assessment by Flow Cytometry ("MDS Flow") - Insights
Flow cytometric immunophenotyping method can be useful in assessing myeloid dysmaturation. In this “Hot Topic,” Dragon Jevremovic, M.D., Ph.D., describes a new flow cytometric test to detect aberrant patterns of expression in the diagnosis...